Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental condition that causes hyperactivity and impulsivity in children and adults. If left untreated ...

Launches of Tuzulby® methylphenidate prolonged-release chewable tablets and Paxneury® guanfacine prolonged-release tablets, also in 5mg, 6mg, and 7mg strengths Two differentiated treatments exemplify ...

SHANGHAI, Jan. 8, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that China's National Medical Products Administration (NMPA) has approved the New Drug ...

ADHD seems to be on everyone's mind recently. It may seem like ADHD diagnoses are on the rise, but it's more likely that we're just more aware of it now. Thanks to social media, there is a decrease in ...

Adult ADHD has emerged as a significant health concern in the United States, with approximately one-quarter of adults suspecting they may have undiagnosed attention deficit hyperactivity disorder.

The most comprehensive review to date of ADHD treatments has found that medication for children and adults, and cognitive behavioural therapy for adults, remain the most effective approaches, backed ...

Following the changes made today, more New Zealanders with ADHD will have faster access to support as a result of changes to ...

Effective treatment for ADHD often consists of medication, behavioral therapy, and lifestyle changes. Stimulant medications such as Adderall and Ritalin work by altering levels of neurotransmitters in ...